Craft

Advanced
  • Home
  •  / Shuttle Pharmaceuticals
Shuttle Pharmaceuticals

Shuttle Pharmaceuticals

Stock Price

$1.8

2024-10-29

Market Capitalization

$5.3 M

2024-10-29

Shuttle Pharmaceuticals Summary

Company Summary

Overview
Shuttle Pharmaceuticals is a pharmaceutical company leveraging its proprietary technology to develop therapies that are designed to cure cancer. It offers a pipeline of radiation sensitizers and immunotherapy assisting product candidates.
Type
Public
Status
Active
Founded
2012
HQ
Rockville, MD, US | view all locations
Website
https://www.shuttlepharma.com
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Anatoly Dritschilo

    Anatoly Dritschilo, Chairman of the Board and Chief Executive Officer

    • Milton Brown

      Milton Brown, Co-Founder, Chief Scientific Officer for Chemistry, Board Member

      • Steve Richards

        Steve Richards, Board Member

        LocationsView all

        1 location detected

        • Rockville, MD HQ

          United States

          1 Research Ct #450A

        Shuttle Pharmaceuticals Financials

        Summary Financials

        Net income (Q1, 2026)
        ($2.2M)
        Cash (Q1, 2026)
        $1.1M
        EBIT (Q1, 2026)
        ($2.2M)
        Enterprise value
        $4.4M

        Competitors and Similar Companies

        Compare competitors

        Footer menu

        Product

        Solutions

        Resources

        Company

        © Craft.co 2026
        Share price data provided by IEX